18647 studies found for:    updated in the last 60 days
Show Display Options
Rank Status Study
1 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
2 Active, not recruiting Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
Condition: Esophageal Carcinoma
Interventions: Drug: Tetrathiomolybdate (TM);   Procedure: Radiation;   Procedure: Surgery
3 Active, not recruiting
Has Results
Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: 12 Week Stanford V Chemotherapy;   Drug: 4 cycles of VAMP chemotherapy;   Drug: 2 alternating cycles of VAMP/COP chemotherapy;   Drug: 3 alternating cycles of VAMP/COP chemotherapy
4 Recruiting Pompe Disease Registry
Conditions: Glycogen Storage Disease Type II;   Pompe Disease
Intervention:
5 Completed The Early History of Universal Screening for Metabolic Disorders
Conditions: Phenylketonuria;   Galactosemia;   Inborn Errors of Metabolism
Intervention:
6 Terminated A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: GM-CT-01;   Drug: 5-Fluorouracil, Leukovorin, bevacizumab
7 Withdrawn Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
Condition: Kidney Diseases
Intervention: Drug: fondaparinux
8 Recruiting Inflammatory Breast Cancer (IBC) Registry
Condition: Breast Cancer
Interventions: Other: Interview;   Procedure: Blood and Tissue Collection
9 Completed Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression
Condition: Depression
Intervention: Device: Electroconvulsive Therapy (ECT)
10 Completed Clinical Trial of Abstinence-Linked Money Management
Condition: Substance Abuse
Interventions: Behavioral: Advisor-Teller Money Manager;   Behavioral: FIT
11 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
12 Recruiting Safety of Driving After Minor Surgery With Monitored Anesthesia Care
Conditions: Minor Surgical Procedures With Monitored Anesthesia Care.;   Driving Performance After Minor Ambulatory Surgery.
Interventions: Drug: Midazolam;   Drug: Sufentanil;   Drug: Propofol
13 Completed Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
14 Completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: letrozole;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
15 Completed Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
Condition: Alcohol Drinking
Interventions: Drug: Varenicline;   Drug: Varenicline (Chantix)
16 Active, not recruiting Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Recurrent Adult Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: bortezomib;   Drug: decitabine;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Terminated A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors
Condition: Cancer
Intervention: Drug: ALB 109564(a) (12´-methylthiovinblastine dihydrochloride)
18 Completed
Has Results
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Condition: In Vitro Fertilization
Interventions: Drug: Corifollitropin alfa;   Biological: RecFSH / Follitropin beta (Days 1 to 7);   Drug: Placebo Corifollitropin alfa;   Drug: Placebo RecFSH / follitropin beta;   Biological: RecFSH / Follitropin beta (Days 8 to hCG);   Drug: Ganirelix;   Biological: hCG;   Biological: Progesterone
19 Recruiting Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
Conditions: Influenza Type A;   Influenza Type B
Intervention: Other: Nasopharyngeal Swab
20 Recruiting Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Childhood Cancer;   Cognitive/Functional Effects;   Neurotoxicity;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity
Interventions: Procedure: psychosocial assessment and care;   Procedure: cognitive assessment;   Other: quality-of-life assessment;   Other: questionnaire administration

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years